Diversified Trust’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-11,524
Closed -$128K 945
2024
Q3
$128K Sell
11,524
-7,454
-39% -$82.2K ﹤0.01% 859
2024
Q2
$213K Sell
18,978
-10,570
-36% -$123K 0.01% 773
2024
Q1
$367K Buy
29,548
+925
+3% +$12.1K 0.01% 600
2023
Q4
$400K Buy
28,623
+1,781
+7% +$24.7K 0.01% 568
2023
Q3
$396K Buy
+26,842
New +$378K 0.02% 536
2022
Q3
Sell
-22,418
Closed -$282K 787
2022
Q2
$282K Hold
22,418
0.01% 582
2022
Q1
$243K Hold
22,418
0.01% 694
2021
Q4
$315K Buy
22,418
+1,539
+7% +$25.3K 0.01% 615
2021
Q3
$401K Buy
20,879
+2,848
+16% +$37.8K 0.01% 472
2021
Q2
$178K Hold
18,031
0.01% 720
2021
Q1
$177K Sell
18,031
-1,856
-9% -$15.3K 0.01% 700
2020
Q4
$88K Hold
19,887
﹤0.01% 712
2020
Q3
$86K Buy
+19,887
New +$142K ﹤0.01% 618

Other funds holding DVAX

Diversified Trust's DVAX Position: Q4 2024 in Review

Diversified Trust sold out of Dynavax Technologies (DVAX) in Q4 2024, closing a stake of 11,524 shares — an estimated $128K sold.

Diversified Trust first reported a position in DVAX in Q3 2020 and held it in 13 quarters. The position peaked at $401K in Q3 2021. 256 funds tracked by Wall St. Rank hold DVAX as of Q4 2024.

  • Diversified Trust reported no remaining Dynavax Technologies position as of Q4 2024 after selling out during the quarter.
  • Diversified Trust sold 11,524 Dynavax Technologies shares in Q4 2024, an estimated $128K.
  • Diversified Trust first reported a position in Dynavax Technologies in Q3 2020 and held it in 13 quarters.
  • Diversified Trust's Dynavax Technologies position peaked at $401K in Q3 2021.
  • 256 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2024.

Based on Diversified Trust's 13F filing for Q4 2024, filed 7 Jan 2025.